Clover Health Earns Top Honors in U.S. News & World Report's 2027 Medicare Advantage Ratings Across Three States

Clover Health plans are named Best Medicare Advantage Plans in New Jersey, Georgia, and South Carolina, scoring highest in all three states for Best for Care Continuity.

WILMINGTON, Del., Oct. 19, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health” or “Clover”), a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare, today announced that it earned top distinctions across New Jersey, Georgia, and South Carolina in U.S. News & World Report's 2027 Best Insurance Companies for Medicare Advantage (“MA”) ratings. The recognition highlights key areas of Clover's approach to MA, including preventive care, continuity of care, and strong physician relationships.

“For beneficiaries, having a health plan they can rely on means being able to see the doctors they trust, get preventive care, and know someone is helping connect the dots across their healthcare,” said Jamie Reynoso, CEO of Medicare Advantage, Clover Health. “These ratings reflect the work our physicians and local teams do every day, supported by clinical insights from Counterpart Assistant, and reinforce the value of a MA model built around choice, continuity, and putting members first.”

In the 2027 U.S. News ratings, Clover Health plans were recognized as Best Medicare Advantage Plans in South Carolina, Georgia, and New Jersey, with the following distinctions:

• Highest scores in the state of New Jersey for Best Medicare Advantage Plans for Care Continuity; recognized as Best Overall and Best for Screening & Prevention
• Highest scores in the state of Georgia for Best Medicare Advantage Plans Overall and Best for Care Continuity; tied as Best for Screening & Prevention
• Highest scores in the state of South Carolina in all three categories: Best Medicare Advantage Plans Overall, Best for Screening & Prevention, and Best for Care Continuity
  
  

Supporting Physicians and More Connected Care

This designation follows the announcement of Clover’s market-leading performance on core Healthcare Effectiveness Data and Information Set (“HEDIS®”¹) measures with a score of 4.82 out of 5 Stars², ranking #1 among non-SNP PPO plans with over 2,000 members for the third year in a row.

Clover's wide-network PPO MA model is supported by Counterpart Assistant, its physician-facing technology platform, which provides data-driven clinical insights to help physicians identify care gaps, make informed decisions, and coordinate care. The technology supports physicians' independent clinical judgment and is also offered to external healthcare organizations through Clover's subsidiary, Counterpart Health.

The 2027 Annual Enrollment Period runs from October 15 through December 7, 2026. Clover Health plans are available to 5.2 million Medicare-eligible beneficiaries within 203 counties across five states. Plans available based on location are available to view here.

About Clover Health:

Clover Health (Nasdaq: CLOV) is a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare. This includes a focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. For our members, we provide PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on our flagship wide-network, high-choice PPO plans. For healthcare providers outside Clover Health's Medicare Advantage plan, we extend the benefits of our data-driven technology platform to a wider audience via our subsidiary, Counterpart Health, and aim to enable enhanced patient outcomes and reduced healthcare costs on a nationwide scale. Clover Health has published data demonstrating the technology’s impact on Medication Adherence, Congestive Heart Failure, Chronic Obstructive Pulmonary Disease, and in Underserved Populations as well as the earlier identification and management of Diabetes and Chronic Kidney Disease.

Investor Relations:

Ryan Schmidt
investors@cloverhealth.com

Press Inquiries:
press@cloverhealth.com

Clover Health is a PPO and HMO organization with a Medicare contract. Enrollment in Clover Health depends on contract renewal.

Y0129_26EX091F_C

__________________________
¹ HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA)
² This analysis focuses on performance by non-SNP PPO plans with over 2,000 lives as of September 1, 2024, 2025, and 2026 on HEDIS measures applicable to non-SNPs that were used for CMS’s MY 2023, MY 2024, and MY 2025 Star ratings, applying the measure ranges used by CMS. Medicare evaluates plans based on a 5-star rating system. Star Ratings are calculated each year and may change from one year to the next.